Pour prendre connaissance de l’abstract :

Maria Elena Santolaya et al. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile : a phase 2b/3 randomised, observer-blind, placebo-controlled study. The Lancet, Early Online Publication, 18 January 2012
doi:10.1016/S0140-6736(11)61713-3-